Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

NCT00209742 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: UFT
DRUG: USEL/Leucovorin
DRUG: Krestin

Sponsor

Hokkaido Gastrointestinal Cancer Study Group

Collaborators

[object Object]